1. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine;Polack;N Engl J Med,2020
2. Neutralizing activity of BNT162b2-elicited Serum—preliminary report;Liu;N Engl J Med,2021
3. The effectiveness of the first dose of BNT162 b 2 vaccine in reducing SARS-CoV-2 infection 13-24 days after immunization: real-world evidence;Chodcik;Medrxiv,2021
4. Estimating the effectiveness of the Pfizer COVID-19 BNT162b2 vaccine after a single dose. A reanalysis of a study of'real-world'vaccination outcomes from Israel;Hunter;Medrxiv,2021
5. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults;Mulligan;Nature,2020